Dr. Galici has a background in Drug Discovery and Clinical Development with expertise in Pharmacology. He has over 15 years of experience successfully and strategically planning and delivering scientific, medical communications and global regulatory submissions to support Oncology, Vaccine, Rare Disease, Neuroscience, Pain, Immunology and Inflammation, and Consumer Health (nutrition, Rx-to-OTC switch) programs. He is currently the co-chair of the DIA MASC forum.

Elizabeth Brown is the Executive Director, Head of Clinical Transparency Communications at Merck & Co, Inc., where she oversees clinical trial registration and results disclosure, as well as health literacy deliverables (ICF/PLS). She has led people, projects, and initiatives in biopharma for 20+ years, spanning laboratory science, clinical research, regulatory, medical writing, and organizational leadership. With her project and people management focus, she has developed a passion for developing people, advising teams, and providing strategic guidance how to create efficient, effective, and high-quality scientific communication deliverables.

Kim Jochman, PhD, RAC, is a regulatory medical writing leader, with a career spanning almost 2 decades and expertise across a wide array of document types, development phases, and therapeutic areas. Kim is deeply committed to talent development, spearheading medical writing development programs at Merck, including summer internships, an entry-level Associate Medical Writer program, and a cross-development program. She champions the advancement of new technology by driving change management initiatives that empower her team and enhance operational efficiency. Kim is also active with the American Medical Writers Association (AMWA) and is a 2024 AMWA Fellow, an AMWA educator, and a past 2-time Carolinas Chapter President.